Published in Healthcare Finance, Tax and Law Weekly, October 27th, 2004
LemnaGene SA also announced the production of its first transgenic Spirodela containing genes of interest to industrial partners.
Georges Freyssinet, the chief executive officer of LemnaGene SA, commented, "This new facility is a big plus for us. We can now produce efficiently transgenic Spirodela...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.